Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00338754 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00645892 ·Status: COMPLETED ·Phase: PHASE2

MAP Study: Methotrexate and Adalimumab in Psoriasis

NCT03217734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

NCT01401452 ·Status: COMPLETED

Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis

NCT00195689 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

NCT02016482 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

NCT00566722 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

NCT01646073 ·Status: COMPLETED ·Phase: PHASE3

The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab

NCT00833729 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

NCT00927069 ·Status: COMPLETED ·Phase: PHASE3

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

NCT02016105 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

NCT03236870 ·Status: COMPLETED

A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis

NCT00513370 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

NCT00338143 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

NCT02533375 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00570986 ·Status: COMPLETED ·Phase: PHASE3

Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment

NCT01316224 ·Status: COMPLETED

Adalimumab in Adult Japanese Subjects With Psoriasis

NCT00647400 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Apremilast in Palmo-Plantar Psoriasis

NCT02400749 ·Status: COMPLETED ·Phase: PHASE4

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

NCT00735787 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

NCT01970488 ·Status: COMPLETED ·Phase: PHASE3

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

NCT03721172 ·Status: COMPLETED ·Phase: PHASE3

A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

NCT00427362 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

NCT01202565 ·Status: COMPLETED

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

NCT04453137 ·Status: COMPLETED ·Phase: PHASE3